Your browser doesn't support javascript.
loading
Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.
Shima, Hiroaki; Tsurita, Giichiro; Wada, Satoshi; Hirohashi, Yoshihiko; Yasui, Hiroshi; Hayashi, Hiroshi; Miyakoshi, Takashi; Watanabe, Kazue; Murai, Aiko; Asanuma, Hiroko; Tokita, Serina; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Nakae, Yutaka; Sugita, Osamu; Ito, Yoichi M; Ota, Yasunori; Kimura, Yasutoshi; Kutomi, Goro; Hirata, Koichi; Mizuguchi, Toru; Imai, Kohzoh; Takemasa, Ichiro; Sato, Noriyuki; Torigoe, Toshihiko.
Afiliación
  • Shima H; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tsurita G; Department of Surgery, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Wada S; Department of Clinical Diagnostic Oncology, Showa University, Tokyo, Japan.
  • Hirohashi Y; Cancer Vaccine Center, Kanagawa Cancer Center, Kanagawa, Japan.
  • Yasui H; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hayashi H; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Miyakoshi T; Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan.
  • Watanabe K; Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan.
  • Murai A; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Asanuma H; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tokita S; Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kubo T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nakatsugawa M; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kanaseki T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tsukahara T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nakae Y; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sugita O; Collaboration Center for Community and Industry, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Ito YM; Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan.
  • Ota Y; Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Kimura Y; Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kutomi G; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hirata K; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Mizuguchi T; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Imai K; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Takemasa I; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Sato N; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Torigoe T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Cancer Sci ; 110(8): 2378-2385, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31218770
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Péptidos / Adenocarcinoma / Interferón beta / Vacunas contra el Cáncer / Survivin Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Péptidos / Adenocarcinoma / Interferón beta / Vacunas contra el Cáncer / Survivin Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido